Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory P Forlenza

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Diabetes Technology & Therapeutics|April 19, 2017
Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the PatientGregory P Forlenza
Diabetes Technology & Therapeutics|June 7, 2019
Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections TherapyGregory P Forlenza
Diabetes Technology & Therapeutics|November 6, 2025
<i>Letter:</i> Scientific and Clinical Evaluation of "Dexcom's Fatal Flaws" by HunterbrookGregory P Forlenza
Diabetes Technology & Therapeutics|March 23, 2018
Ongoing Debate About Models for Artificial Pancreas Systems and In Silico StudiesGregory P Forlenza
Diabetes Technology & Therapeutics|July 8, 2017
Relevance of Bolus Calculators in Current Hybrid Closed Loop SystemsGregory P Forlenza
Current Opinion in Endocrinology, Diabetes, and Obesity|August 17, 2011
The epidemic of type 1 diabetes: what is it telling us?Gregory P Forlenza, Marian Rewers
Journal of Diabetes Science and Technology|March 7, 2020
Suicide via Intentional Insulin Overdose Through First Commercial Hybrid Closed-LoopViral N Shah, Gregory P Forlenza
Diabetes Technology & Therapeutics|February 15, 2020
Use of Machine Learning and Hybrid Closed Loop Insulin Delivery at Diabetes CampsKasserine A Taylor, Gregory P Forlenza
Pediatric Endocrinology Reviews : PER|April 2, 2013
Diabetic retinopathy in childrenGregory P Forlenza, Michael W Stewart
Diabetes Technology & Therapeutics|March 21, 2024
Response to: MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias-Response to Inaccurate AllegationsGregory P Forlenza, Jennifer L Sherr
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Diabetes Technology & Therapeutics|April 19, 2017
Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the PatientGregory P Forlenza
Diabetes Technology & Therapeutics|June 7, 2019
Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections TherapyGregory P Forlenza
Diabetes Technology & Therapeutics|November 6, 2025
<i>Letter:</i> Scientific and Clinical Evaluation of "Dexcom's Fatal Flaws" by HunterbrookGregory P Forlenza
Diabetes Technology & Therapeutics|March 23, 2018
Ongoing Debate About Models for Artificial Pancreas Systems and In Silico StudiesGregory P Forlenza
Diabetes Technology & Therapeutics|July 8, 2017
Relevance of Bolus Calculators in Current Hybrid Closed Loop SystemsGregory P Forlenza
Current Opinion in Endocrinology, Diabetes, and Obesity|August 17, 2011
The epidemic of type 1 diabetes: what is it telling us?Gregory P Forlenza, Marian Rewers
Journal of Diabetes Science and Technology|March 7, 2020
Suicide via Intentional Insulin Overdose Through First Commercial Hybrid Closed-LoopViral N Shah, Gregory P Forlenza
Diabetes Technology & Therapeutics|February 15, 2020
Use of Machine Learning and Hybrid Closed Loop Insulin Delivery at Diabetes CampsKasserine A Taylor, Gregory P Forlenza
Pediatric Endocrinology Reviews : PER|April 2, 2013
Diabetic retinopathy in childrenGregory P Forlenza, Michael W Stewart
Diabetes Technology & Therapeutics|March 21, 2024
Response to: MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias-Response to Inaccurate AllegationsGregory P Forlenza, Jennifer L Sherr
Pageof 15